{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:53:35Z","timestamp":1773770015106,"version":"3.50.1"},"reference-count":33,"publisher":"FapUNIFESP (SciELO)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ci\u00eanc. sa\u00fade coletiva"],"published-print":{"date-parts":[[2014,6]]},"abstract":"<jats:p>O Escore de Framingham (EF) \u00e9 utilizado para estratificar o risco cardiovascular. O presente estudo objetivou identificar, entre os hipertensos assistidos pela Estrat\u00e9gia Sa\u00fade da Fam\u00edlia (ESF), a preval\u00eancia dos fatores de risco utilizados no EF e do uso de drogas que reduzem o risco cardiovascular. Trata-se de estudo transversal, que avaliou amostra aleat\u00f3ria de hipertensos da ESF no norte de Minas Gerais. Os dados foram coletados em entrevistas e consulta aos prontu\u00e1rios. Foram avaliados 505 hipertensos em 9 munic\u00edpios da regi\u00e3o, com predom\u00ednio de mulheres, 325 (64,4%) e m\u00e9dia de idade de 66,4 anos. Em 90% dos hipertensos houve pelo menos 1 fator de risco associado. O agrupamento de 3 ou mais fatores ocorreu em 79 (15,7%) pacientes. Dislipidemia foi encontrada em 188 (37,2%), diabetes em 101 (20%) e tabagismo em 36 (7,1%). O uso de anti-hipetensivo foi observado em 481 (95,2%) hipertensos. O uso de outras drogas cardioprotetoras foi maior entre pacientes 3 ou mais fatores de risco: 45,6% usavam antiagregantes plaquet\u00e1rios e 27,8% usavam hipolipemiantes. A preval\u00eancia de fatores de risco do EF na popula\u00e7\u00e3o estudada mostrou-se bastante elevada e o uso de drogas cardioprotetoras mostrou-se restrito. Estrat\u00e9gias para ampliar o uso do EF podem melhorar o manejo da hipertens\u00e3o arterial na ESF.<\/jats:p>","DOI":"10.1590\/1413-81232014196.20092013","type":"journal-article","created":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T15:34:49Z","timestamp":1401896089000},"page":"1731-1739","source":"Crossref","is-referenced-by-count":14,"title":["Fatores de risco cardiovascular do Escore de Framingham entre hipertensos assistidos por equipes de Sa\u00fade da Fam\u00edlia"],"prefix":"10.1590","volume":"19","author":[{"given":"Henderson Barbosa","family":"Pimenta","sequence":"first","affiliation":[{"name":"Universidade Estadual de Montes Claros, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f4nio Prates","family":"Caldeira","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Montes Claros, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","series-title":"Global status report on noncommunicable diseases 2010","year":"2011"},{"issue":"3","key":"ref2","first-page":"313","article-title":"Multivariate risk assessment and risk score cards in hypertension","volume":"3","author":"Tocci G","year":"2007","journal-title":"Vasc Health Risk Manag"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1590\/S0102-311X2009000100012","article-title":"Preval\u00eancia de fatores de risco para doen\u00e7as cardiovasculares entre homens de uma popula\u00e7\u00e3o urbana do Sudeste do Brasil","volume":"25","author":"Van Eyken EBBD","year":"2009","journal-title":"Cad Saude Publica"},{"issue":"12","key":"ref4","first-page":"1462","article-title":"The task force for the management of arterial hypertension of the European Society of Hypertension, The task force for the management of arterial hypertension of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension","volume":"28","author":"Mancia G","year":"2007","journal-title":"Eur Heart J"},{"issue":"Supl. 1","key":"ref5","first-page":"1","article-title":"VI Diretrizes Brasileiras de Hipertens\u00e3o","volume":"95","year":"2010","journal-title":"Arq Bras Cardiol"},{"key":"ref6","series-title":"Hipertens\u00e3o arterial sist\u00eamica para o Sistema \u00danico de Sa\u00fade","year":"2006"},{"issue":"18","key":"ref7","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of Coronary Heart Disease Using Risk Factor Categories","volume":"97","author":"Wilson PWF","year":"1998","journal-title":"Circulation"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ahj.2007.02.027","article-title":"Prediction of first coronary events with the Framingham score: A systematic review","volume":"153","author":"Eichler K","year":"2007","journal-title":"Am Heart J"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1471-2458-13-219","article-title":"Evaluation of a community intervention program in Japan using Framingham risk score and estimated 10-year coronary heart disease risk as outcome variables: a non-randomized controlled trial","volume":"13","author":"Zhu B","year":"2013","journal-title":"BMC Public Health"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1590\/S1020-49892009000600004","article-title":"Per\u00fbl de risco cardiovascular e autoavalia\u00e7\u00e3o da sa\u00fade no Brasil: estudo de base populacional","volume":"25","author":"Pereira JC","year":"2009","journal-title":"Rev Panam Salud Publica"},{"issue":"5","key":"ref11","first-page":"1124","article-title":"Risk factors and complications in patients with hypertension\/diabetes in a regional health district of northeast Brazil","volume":"46","author":"Santos JC","year":"2012","journal-title":"Rev Esc Enferm USP"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1590\/S1413-81232011000200026","article-title":"Avalia\u00e7\u00e3o da implanta\u00e7\u00e3o da aten\u00e7\u00e3o \u00e0 hipertens\u00e3o arterial pelas equipes de Sa\u00fade da Fam\u00edlia do munic\u00edpio do Recife (PE, Brasil)","volume":"16","author":"Costa JMBS","year":"2011","journal-title":"Cien Saude Colet"},{"issue":"Supl. 1","key":"ref13","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1590\/S1413-81232011000700074","article-title":"Controle da hipertens\u00e3o arterial e fatores associados na aten\u00e7\u00e3o prim\u00e1ria em Unidades B\u00e1sicas de Sa\u00fade localizadas na Regi\u00e3o Oeste da cidade de S\u00e3o Paulo","volume":"16","author":"Pierin AMG","year":"2011","journal-title":"Cien Saude Colet"},{"key":"ref14","series-title":"Censo nacional de 2010","year":"2010"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"c1693","DOI":"10.1136\/bmj.c1693","article-title":"Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study","volume":"340","author":"Chamnan P","year":"2010","journal-title":"BMJ"},{"issue":"6","key":"ref16","first-page":"1206","article-title":"Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian AV","year":"2003","journal-title":"Hypertension"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4025\/actascihealthsci.v31i1.4492","article-title":"Preval\u00eancia de fatores de risco para doen\u00e7as cardio vasculares em hipertensos cadastrados em unidade de sa\u00fade da fam\u00edlia","volume":"31","author":"Girotto E","year":"2009","journal-title":"Acta Sci Health Sci"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5020\/18061230.2012.p287","article-title":"Estratifica\u00e7\u00e3o do risco cardiovascular global em hipertensos atendidos numa unidade de sa\u00fade da fam\u00edlia de Parna\u00edba, Piau\u00ed","volume":"25","author":"Nascimento ES","year":"2012","journal-title":"Rev Bras Promo\u00e7 Sa\u00fade"},{"issue":"4","key":"ref19","first-page":"245","article-title":"Hipertens\u00e3o: um estado pr\u00f3-tromb\u00f3tico","volume":"14","author":"Teles CPS","year":"2007","journal-title":"Rev Bras Hipertens"},{"issue":"Supl.","key":"ref20","doi-asserted-by":"crossref","first-page":"3s","DOI":"10.1016\/S0895-7061(99)00252-6","article-title":"Risk Stratification in Hypertension: New Insights from the Framingham Study","volume":"13","author":"Kannel WB","year":"2000","journal-title":"Am J Hypetens"},{"issue":"Supl. 8","key":"ref21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1524-6175.2006.05834.x","article-title":"Global cardiovascular risk reduction: new concepts and therapeutic opportunities","volume":"8","author":"Giles TD","year":"2006","journal-title":"J Clin Hypertens"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/CIR.0b013e31820faaf8","article-title":"Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women 2011 Update: A Guideline From the American Heart Association","volume":"123","author":"Mosca L","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"ref23","first-page":"55","article-title":"Physical activity guidelines for older adults","volume":"81","author":"Elsawy B","year":"2010","journal-title":"Am Fam Physician"},{"issue":"8","key":"ref24","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1590\/S0102-311X2010000800011","article-title":"Tabagismo associado a outros fatores comportamentais de risco de doen\u00e7as e agravos cr\u00f4nicos n\u00e3o transmiss\u00edveis","volume":"26","author":"Berto SJP","year":"2010","journal-title":"Cad Saude Publica"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/gerona\/gln016","article-title":"Prevalence, Awareness, and Management of Hypertension, Dyslipidemia, and Diabetes Among United States Adults Aged 65 and Older","volume":"64","author":"McDonald M","year":"2009","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"9","key":"ref26","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/CIRCULATIONAHA.111.030189","article-title":"Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008","volume":"124","author":"Egan BM","year":"2011","journal-title":"Circulation"},{"issue":"12","key":"ref27","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.2337\/dc09-1297","article-title":"Aspirin for the Primary Prevention of Cardiovascular Events","volume":"32","author":"Calvin AD","year":"2009","journal-title":"Diabetes Care"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archinternmed.2011.628","article-title":"Effect of Aspirin on Vascular and Nonvascular Outcomes","volume":"172","author":"Seshasai SR","year":"2012","journal-title":"Arch Intern Med"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/aje\/kws204","article-title":"Clinical Usefulness of the Framingham Cardiovascular Risk Profile Beyond Its Statistical Performance: The Tehran Lipid and Glucose Study","volume":"176","author":"Khalili D","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"3","key":"ref30","first-page":"265","article-title":"Global Risk of Coronary Heart Disease: Assessment and Aplication","volume":"82","author":"Vieira AJ","year":"2010","journal-title":"Am Fam Physician"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1472-6963-12-20","article-title":"Use of global coronary heart disease risk assessment in practice: a cross-sectional survey of a sample of U. S. physicians","volume":"12","author":"Shillinglaw B","year":"2012","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/HCO.0b013e3283021c70","article-title":"Hypertension and socioeconomic status","volume":"23","author":"Grotto I","year":"2008","journal-title":"Curr Opin Cardiol"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1590\/S1413-81232012000100002","article-title":"A Promo\u00e7\u00e3o da Sa\u00fade e a Preven\u00e7\u00e3o Integrada dos Fatores de Risco para Doen\u00e7as Cardiovasculares","volume":"17","author":"Ribeiro AG","year":"2012","journal-title":"Cien Saude Colet"}],"container-title":["Ci\u00eancia &amp; Sa\u00fade Coletiva"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/csc\/v19n6\/1413-8123-csc-19-06-01731.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T03:59:44Z","timestamp":1565495984000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1413-81232014000601731&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1413-81232014000601731"],"URL":"https:\/\/doi.org\/10.1590\/1413-81232014196.20092013","relation":{},"ISSN":["1413-8123"],"issn-type":[{"value":"1413-8123","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}